NASDAQ:AHCO • US00653Q1022
The current stock price of AHCO is 9.715 USD. Today AHCO is up by 0.15%. In the past month the price decreased by -9.51%. In the past year, price increased by 1.04%.
ChartMill assigns a technical rating of 1 / 10 to AHCO. When comparing the yearly performance of all stocks, AHCO is a bad performer in the overall market: 70.25% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to AHCO. While AHCO is still in line with the averages on profitability rating, there are concerns on its financial health.
On February 24, 2026 AHCO reported an EPS of -0.76 and a revenue of 846.29M. The company missed EPS expectations (-312.89% surprise) and missed revenue expectations (-0.23% surprise).
14 analysts have analysed AHCO and the average price target is 13.64 USD. This implies a price increase of 40.43% is expected in the next year compared to the current price of 9.715.
For the next year, analysts expect an EPS growth of 229.95% and a revenue growth 7.34% for AHCO
Over the last trailing twelve months AHCO reported a non-GAAP Earnings per Share(EPS) of -0.78. The EPS decreased by -230% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.63% | ||
| ROE | -4.63% | ||
| Debt/Equity | 1.15 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 20.61 | 113.755B | ||
| COR | CENCORA INC | 17.83 | 68.511B | ||
| CAH | CARDINAL HEALTH INC | 18.44 | 51.074B | ||
| HSIC | HENRY SCHEIN INC | 14.22 | 8.75B | ||
| ACH | ACCENDRA HEALTH INC | 4.36 | 190.336M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 16.331M |
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Conshohocken, Pennsylvania and currently employs 10,900 full-time employees. The company went IPO on 2018-02-21. The firm provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company operates in 50 states through its network of over 670 locations in 47 states.
IPO: 2018-02-21
ADAPTHEALTH CORP
555 East North Lane, Suite 5075
Conshohocken PENNSYLVANIA 19462 US
CEO: Luke McGee
Employees: 10500
Phone: 16104244515
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Conshohocken, Pennsylvania and currently employs 10,900 full-time employees. The company went IPO on 2018-02-21. The firm provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company operates in 50 states through its network of over 670 locations in 47 states.
The current stock price of AHCO is 9.715 USD. The price increased by 0.15% in the last trading session.
AHCO does not pay a dividend.
AHCO has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
14 analysts have analysed AHCO and the average price target is 13.64 USD. This implies a price increase of 40.43% is expected in the next year compared to the current price of 9.715.
ADAPTHEALTH CORP (AHCO) will report earnings on 2026-05-04, before the market open.
The outstanding short interest for ADAPTHEALTH CORP (AHCO) is 6.41% of its float.